Class II drug recalls - moderate risk
Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.
14,543 recalls, newest first.
Oct 6, 2017
Class II · Moderate risk
Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared sibutramine, phenolphthalein, and n-desmethyl sibutramine, making this an unapproved drug for which safety and efficacy have not been established and therefore, subject to recall.
Oct 6, 2017
Class II · Moderate risk
Failed Impurities/Degradation Specifications: slightly elevated levels of phthalic acid.
Oct 5, 2017
Class II · Moderate risk
Subpotent Drug: The laminate used to make the pouches was reversed such that the aluminum layer was in contact with the product causing an exothermic reaction between the free iodine and the aluminum.
Oct 2, 2017
Class II · Moderate risk
Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity was observed during the 18 month stability testing.
Sep 28, 2017
Class II · Moderate risk
Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepam
Sep 27, 2017
Class II · Moderate risk
Microbial Contamination of Non-Sterile Products
Sep 27, 2017
Class II · Moderate risk
CGMP Deviations; FDA analysis deterrmined that the product does not contain glutamine and two unknown impurities were observed
Sep 26, 2017
Class II · Moderate risk
Sep 26, 2017
Class II · Moderate risk
Failed Impurities/Degradation Specifications: Out-of-specification result for an unknown impurity.
Sep 25, 2017
Class II · Moderate risk
Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product.
Sep 21, 2017
Class II · Moderate risk
Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%.
Sep 21, 2017
Class II · Moderate risk
Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%.
Sep 21, 2017
Class II · Moderate risk
Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%.
Sep 21, 2017
Class II · Moderate risk
Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%.
Sep 21, 2017
Class II · Moderate risk
Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%.
Sep 21, 2017
Class II · Moderate risk
Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%.
Sep 21, 2017
Class II · Moderate risk
Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%.
Sep 21, 2017
Class II · Moderate risk
Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%.
Sep 21, 2017
Class II · Moderate risk
Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%.
Sep 21, 2017
Class II · Moderate risk
Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%.
Sep 21, 2017
Class II · Moderate risk
Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%.
Sep 21, 2017
Class II · Moderate risk
Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%.
Sep 21, 2017
Class II · Moderate risk
Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%.
Sep 21, 2017
Class II · Moderate risk
Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%.
Sep 21, 2017
Class II · Moderate risk
Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%.